KEAP1 and non-small cell lung carcinoma: Therefore, it may be of interest to scan for this epigenetic event in specific oncogenic-addicted NSCLC patients, taking into consideration that the potential inclusion of KEAP1 methylation in a molecular predictive/prognostic algorithm would first need a clinically validated cut-off setting specific for lung cancer.